| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/01/2004 | US6743428 Angiogenesis inhibitor |
| 06/01/2004 | CA2279943C Treatment of skin disorders |
| 05/27/2004 | WO2004043982A2 Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone |
| 05/27/2004 | WO2004043968A1 N-sulfonylaminothiazole |
| 05/27/2004 | WO2004043482A1 Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser |
| 05/27/2004 | WO2004043481A2 Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto |
| 05/27/2004 | WO2004043473A1 Composition for restoring damaged skin |
| 05/27/2004 | WO2004043471A1 Antipruritic drug |
| 05/27/2004 | WO2004043424A1 Method of stimulating hair growth using benzopyrans |
| 05/27/2004 | WO2004043362A2 Acyl guanidine compounds and use thereof |
| 05/27/2004 | WO2004043331A2 Dermastick thickened ointment |
| 05/27/2004 | WO2004021968A3 Solution for ungual application |
| 05/27/2004 | WO2004018465A3 Benzonaphthyridines with pde 3/4 inhibiting activity |
| 05/27/2004 | WO2003104197A9 Polymorphic form xvi of fexofenadine hydrochloride |
| 05/27/2004 | WO2003095637B1 Combination of a growth factor and a protease enzyme |
| 05/27/2004 | WO2003073986A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/27/2004 | WO2003059276B1 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 05/27/2004 | WO2003035050A3 Use of tyrosine kinase inhibitors for promoting hair growth |
| 05/27/2004 | WO2003018748A3 Anti-cancer and wound healing compounds |
| 05/27/2004 | WO2003011262A3 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 05/27/2004 | WO2003002109A3 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 05/27/2004 | WO2002102854A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 05/27/2004 | WO2002062362A8 Antiviral and antibacterial composition |
| 05/27/2004 | WO2002060480A9 Methods for treating or preventing skin disorders using cd2-binding agents |
| 05/27/2004 | US20040102633 For therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper- reactivity, cough; inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 05/27/2004 | US20040102630 For therapy of cancer, auto-immune diseases, cardiovascular diseases, infectious diseases, nephrological diseases, neurodegenerative diseases and viral infections |
| 05/27/2004 | US20040102512 Statins reduce or repress T-lymphocyte activation mediated by MHC class II or CD40; new target is alternative to cytokine inhibitors |
| 05/27/2004 | US20040102510 Cancer; the compounds interact with the amino acids in the catalytic region of PKs and bind in the general space normally occupied by the adenine ring of ATP |
| 05/27/2004 | US20040102508 Naphathalene derivatives which bind to the ep4 receptor |
| 05/27/2004 | US20040102506 Pyrazole compositions useful as inhibitors of ERK |
| 05/27/2004 | US20040102496 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 05/27/2004 | US20040102483 Chemical compounds |
| 05/27/2004 | US20040102471 Viricides; anticancer agents |
| 05/27/2004 | US20040102460 Phosphodiesterase 4 inhibitors |
| 05/27/2004 | US20040102455 Autoimmune diseases; antiinflammatory agents; antiallergens; viricides; anticancer agents |
| 05/27/2004 | US20040102447 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 05/27/2004 | US20040102446 Tricyclic quinoxaline derivatives as a uv filter |
| 05/27/2004 | US20040102441 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 05/27/2004 | US20040102436 Heterocyclic compound derivatives and medicines |
| 05/27/2004 | US20040102429 Zinc salt compositions for the prevention of dermal and mucosal irritation |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | US20040102416 Antiallergic composition |
| 05/27/2004 | US20040102410 In particular, invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors |
| 05/27/2004 | US20040102406 Phosphorothioate oligonucleotides directed to a subunit of an integrin vitronectin receptor to inhibit angiogenesis and/or metastasis |
| 05/27/2004 | US20040102376 Use of rgm and its modulators |
| 05/27/2004 | US20040101931 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 05/27/2004 | US20040101882 Secreted proteins |
| 05/27/2004 | US20040101593 Preventives or remedies for tumor of human papillomaviral disease |
| 05/27/2004 | US20040101581 Chinese herbs extract |
| 05/27/2004 | US20040101580 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same |
| 05/27/2004 | US20040101538 Synergistic mixture of terbinafine with diclofenac or indomethacin; fungicide |
| 05/27/2004 | US20040101508 Use of extracts of the plant litchi chinensis sonn. |
| 05/27/2004 | DE10253591A1 Use of polymers of basic amino group-containing monomers, e.g. N-vinyl-imidazole, as additives for cosmetic, dermatological or pharmaceutical formulations, especially delayed-release salicylic acid preparations |
| 05/27/2004 | CA2505523A1 Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto |
| 05/27/2004 | CA2505249A1 N-sulfonylaminothiazole |
| 05/27/2004 | CA2504807A1 Dermastick thickened ointment |
| 05/26/2004 | EP1422292A1 Fermentation product of cyptoporus volvatus and its preparation method and use |
| 05/26/2004 | EP1422224A1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin |
| 05/26/2004 | EP1422217A2 Aminocyclohexyl ether compounds and uses thereof |
| 05/26/2004 | EP1421948A2 Use of botulinum toxins for treating sweating in humans |
| 05/26/2004 | EP1421942A1 Use of glycyrrhizin and its derivatives as RANTES inducers |
| 05/26/2004 | EP1421940A1 Medical composition for external use for dermatosis |
| 05/26/2004 | EP1421218A2 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
| 05/26/2004 | EP1421191A2 Therapeutic binding molecules |
| 05/26/2004 | EP1421108A2 Antimicrobial and anti-inflammatory peptides |
| 05/26/2004 | EP1421099A1 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 05/26/2004 | EP1421082A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 05/26/2004 | EP1421075A1 Piperidine derivatives useful as ccr5 antagonists |
| 05/26/2004 | EP1420829A2 Immunomodulatory compositions, formulations, and methods for use thereof |
| 05/26/2004 | EP1420824A2 Compound |
| 05/26/2004 | EP1420810A1 Modulation of leukocyte-endothelial interactions following ischemia |
| 05/26/2004 | EP1420801A1 Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| 05/26/2004 | EP1420800A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 05/26/2004 | EP1420797A1 Dermal therapy using phosphate derivatives of electron transfer agents |
| 05/26/2004 | EP1420796A1 Androgen receptor modulators and methods of use thereof |
| 05/26/2004 | EP1420783A1 Stable emulsion composition |
| 05/26/2004 | EP1420777A2 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| 05/26/2004 | EP1420772A2 Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases |
| 05/26/2004 | EP1420750A2 Method of reducing hair growth by applying alpha-difluoromethylornithine |
| 05/26/2004 | EP1420645A1 Multivesicular emulsion topical delivery systems |
| 05/26/2004 | EP1296996B1 Purine derivatives |
| 05/26/2004 | EP1123110A4 Compositions and methods for promoting tissue repair using heat shock proteins |
| 05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |
| 05/26/2004 | EP0932410B1 Mistletoe (viscum) extracts |
| 05/26/2004 | EP0874819B1 Imides as pde iii, pde iv and tnf inhibitors |
| 05/26/2004 | CN1500097A Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 05/26/2004 | CN1500096A Osteoprotegerin in milk |
| 05/26/2004 | CN1500089A Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain |
| 05/26/2004 | CN1500082A Cyano-5ubstituted dihydropyrimidine compounds and their use to treat diseases |
| 05/26/2004 | CN1500078A Aryl oxime-piperazines useful as CCR5 antagonists |
| 05/26/2004 | CN1499979A Compsns. contg active fraction isolates from hedyotis diffusae and methods of use |
| 05/26/2004 | CN1499977A Compsns. and method of tissue superoxygenation |
| 05/26/2004 | CN1498823A Oil refine and filling system |
| 05/26/2004 | CN1498654A Compsn. of medication for treating burns and scalds |
| 05/26/2004 | CN1498644A Medication for treating burns and scalds |
| 05/26/2004 | CN1498635A Externally applied agent for treating burning and scald |
| 05/26/2004 | CN1498632A Chinese traditional medicine for treating psoriasis |
| 05/26/2004 | CN1498631A Medicine to be taken after being mixed with boiling water of 'Yinxiejing' |
| 05/26/2004 | CN1498628A External burn cream |
| 05/26/2004 | CN1498623A Glycyrrhizic acid and its derivative used as RANTES inducer |